EVIA Life Sciences Inc.

New Filing

CIK: 0002162667·Biotechnology·DELAWARE·Filed: Nov 2, 2026

Total Offering

$5,498,154

Amount Sold

$700,002

Investors

1

First Sale

Oct 23, 2026

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Kosuke Takishima	Related Person
Joshua Raphael Schwab	Related Person
Michael Kim	Related Person
Takahiro Ochiya	Related Person

Company

EVIA Life Sciences Inc.

MIDTOWN TOWER 18F

TOKYO, M0, 107-6218

81 80 2105 3464

SEC Filing

0002162667-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.